Lack of p53 Augments Antitumor Functions in Cytolytic T Cells.

作者: Anirban Banerjee , Krishnamurthy Thyagarajan , Shilpak Chatterjee , Paramita Chakraborty , Pravin Kesarwani

DOI: 10.1158/0008-5472.CAN-15-1798

关键词:

摘要: Repetitive stimulation of T-cell receptor (TCR) with cognate antigen results in robust proliferation and expansion the T cells, also imprints them replicative senescence signatures. Our previous studies have shown that life-span antitumor function cells can be enhanced by inhibiting reactive oxygen species (ROS) or intervening ROS-dependent JNK activation leads to its activation-induced cell death. Because tumor suppressor protein p53 is a redox active transcription factor regulates cellular ROS generation triggers downstream factor-mediating apoptosis, we determined if levels could influence persistence tumor-reactive cells. Using h3T TCR transgenic mice, human tyrosinase epitope-reactive developed on knockout (KO) background, role regulating function. data show as compared h3T-p53 KO exhibited glycolytic commitment correlated increased proliferation, IFNγ secretion, cytolytic capacity, expression stemness gene signature, decreased TGF-β signaling. This effector improved control subcutaneously established murine melanoma after adoptive transfer p53-KO Pharmacological inhibition TCR-transduced using combination inhibitors potentiated persistence. Thus, our highlight key response targeting this pathway potential translational significance therapy. Cancer Res; 76(18); 5229-40. ©2016 AACR.

参考文章(46)
Anna Oksanen, Saara Aittomäki, Dragana Jankovic, Zsuzsanna Ortutay, Kati Pulkkinen, Sanna Hämäläinen, Anne Rokka, Garry L. Corthals, Wendy T. Watford, Ilkka Junttila, John J. O’Shea, Marko Pesu, Proprotein Convertase FURIN Constrains Th2 Differentiation and Is Critical for Host Resistance against Toxoplasma gondii Journal of Immunology. ,vol. 193, pp. 5470- 5479 ,(2014) , 10.4049/JIMMUNOL.1401629
Kornelia Polyak, Yong Xia, Jay L. Zweier, Kenneth W. Kinzler, Bert Vogelstein, A model for p53-induced apoptosis Nature. ,vol. 389, pp. 300- 305 ,(1997) , 10.1038/38525
Hirotoshi Kawashima, Hiroaki Takatori, Kotaro Suzuki, Arifumi Iwata, Masaya Yokota, Akira Suto, Tohru Minamino, Koichi Hirose, Hiroshi Nakajima, Tumor suppressor p53 inhibits systemic autoimmune diseases by inducing regulatory T cells. Journal of Immunology. ,vol. 191, pp. 3614- 3623 ,(2013) , 10.4049/JIMMUNOL.1300509
Flore Kruiswijk, Christiaan F. Labuschagne, Karen H. Vousden, p53 in survival, death and metabolic health: a lifeguard with a licence to kill Nature Reviews Molecular Cell Biology. ,vol. 16, pp. 393- 405 ,(2015) , 10.1038/NRM4007
Steven A. Feldman, Yasmine Assadipour, Isaac Kriley, Stephanie L. Goff, Steven A. Rosenberg, Adoptive Cell Therapy—Tumor-Infiltrating Lymphocytes, T-Cell Receptors, and Chimeric Antigen Receptors Seminars in Oncology. ,vol. 42, pp. 626- 639 ,(2015) , 10.1053/J.SEMINONCOL.2015.05.005
Michael R. Betts, Jason M. Brenchley, David A. Price, Stephen C. De Rosa, Daniel C. Douek, Mario Roederer, Richard A. Koup, Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation Journal of Immunological Methods. ,vol. 281, pp. 65- 78 ,(2003) , 10.1016/S0022-1759(03)00265-5
Armando Rivera, Steve A. Maxwell, The p53-induced gene-6 (proline oxidase) mediates apoptosis through a calcineurin-dependent pathway. Journal of Biological Chemistry. ,vol. 280, pp. 29346- 29354 ,(2005) , 10.1074/JBC.M504852200
E. L. Pearce, M. C. Poffenberger, C.-H. Chang, R. G. Jones, Fueling immunity: insights into metabolism and lymphocyte function. Science. ,vol. 342, pp. 1242454- 1242454 ,(2013) , 10.1126/SCIENCE.1242454
Songguang Ju, Yibei Zhu, Lin Liu, Shao Dai, Changyou Li, Elizabeth Chen, Yukai He, Xueguang Zhang, Binfeng Lu, Gadd45b and Gadd45g are important for anti-tumor immune responses. European Journal of Immunology. ,vol. 39, pp. 3010- 3018 ,(2009) , 10.1002/EJI.200839154
Shicheng Yang, Fang Liu, Qiong J. Wang, Steven A. Rosenberg, Richard A. Morgan, The shedding of CD62L (L-selectin) regulates the acquisition of lytic activity in human tumor reactive T lymphocytes. PLOS ONE. ,vol. 6, ,(2011) , 10.1371/JOURNAL.PONE.0022560